|
N.S. Besova
Conversion therapy for stage IV gastric cancer: a review of prognostic factors and patient selection criteria according to the literature data
|
№6-7 / 2023
|
|
V.F. Semiglazov, P.V. Krivorotko, T.Yu. Semiglazova, A.V. Komyakhov, T.T. Tabagua, M.D. Kazantseva, E.K. Zhiltsova, D.G. Ulrikh, M.V. Chervyak, A.P. Tergoeva, V.V. Klimenko, V.V. Semiglazov
Ixabepilone in the treatment of breast cancer
|
№11-12 / 2022
|
|
I.V. Poddubnaya, N.A. Ognerubov, T.S. Antipova
Thymus hyperplasia after lymphoma drug therapy: the role of PET/CT
|
№7 / 2022
|
|
O.D. Guryeva, M.I. Savelyeva, T.T. Valiev
Influence of pharmacogenetic parameters on clinical variants of methotrexate toxicity in acute lymphoblastic leukemia in children
|
№7 / 2022
|
|
M.M. Konstantinova (1), L.I. Kuzina (2)
Will our clinical practice change with the availability of new diagnostic methods, drug therapy and assessment of its effectiveness? Clinical case: hormone receptor-positive, HER2-negative metastatic breast cancer
|
№11 / 2021
|
|
S.V. Khokhlova
Clinical case of treatment of patient with HRD-positive ovarian cancer
|
№11 / 2021
|
|
T.Yu. Semiglazova (1, 2), Yu.V. Alekseeva (1), E.V. Tkachenko (1), S.M. Sharashenidze (1), I.A. Baldueva (1), S.A. Volchenkov (1), A.K. Kovyazin (1), L.V. Filatova (1, 2), B.S. Kasparov (1), V.V. Semiglazov (1, 3), S.A. Protsenko (1), V.N. Anisimov (1), A.M. Belyaev (1, 3)
Features of examination and systemic treatment of malignant neoplasms in gerontological patients
|
№7 / 2021
|
|
G.G. Khakimova (1, 2), A.A. Tryakin (3), T.N. Zabotina (3)
Dynamics of indicators of systemic and local immunity during treatment in patients with gastric cancer
|
№7 / 2021
|
|
Yu.V. Vakhabova (1), M.A. Polyak (2), E.O. Ignatova (3), V.A. Derzhavin (2), O.A. Anurova (2), D.V. Kalinin (4), V.K. Tokaev (2), E.A. Troshenkov (2)
Apocrine skin appendage carcinoma. Real clinical practice
|
№11 / 2020
|
|
D.D. Sakaeva, R.I. Kunafina, G.M. Almukhametova, T.Kh. Akchulpanov
Experience of using a combination of gemcitabine and carboplatin in the treatment of metastatic collecting duct (Bellini) carcinoma
|
№11 / 2020
|
|
A.V. Novik, T.L. Nekhaeva, A.I. Semenova, A.B. Danilova, D.Kh. Latipova, N.P. Pipia, G.M. Teletaeva, N.A. Avdonkina, A.Yu. Zozulya, M.L. Blokhina, A.P. Oganesyan, S.A. Protsenko, I.A. Baldueva
Ten-year experience of pharmacotherapy for soft tissue sarcomas
|
№11 / 2020
|
|
S.A. Protsenko, G.M. Teletaeva, E.A. Degtiareva, E.V. Levchenko, N.E. Levchenko, A.V. Mishchenko, I.A. Burovik, A.S. Artemyeva, E.N. Imyanitov, A.I. Semenova, A.V. Novik, D.Kh. Latipova
PEComas: what are the treatment options? literature review and personal experience
|
№7 / 2019
|
Русский
